Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|19|20|3669-3678
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.19, Iss.20, 2013-06, pp. : 3669-3678
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Emerging therapies for cystic fibrosis lung disease
By Grasemann Hartmut Ratjen Felix
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. :
Towards a gene therapy for cystic fibrosis lung disease
By Pickles R.J.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. :
Infliximab: Allergic bronchopulmonary aspergillosis: case report
Reactions Weekly, Vol. 1, Iss. 1259, 2009-01 ,pp. :
Fluticasone propionate: Allergic bronchopulmonary aspergillosis: case report
Reactions Weekly, Vol. 1, Iss. 1387, 2012-01 ,pp. :